ReviewPublished 23 September 2026Therapeutic reprogramming of natural killer cells for solid tumors: expanding frontiers into rare and ultra-rare malignanciesFrancesca Rosato · James W. HodgeFrontiers in Molecular Biosciencesdoi 10.3389/fmolb.2026.1955532